Consultations - Medicare Benefits Schedule Review

A key element of the Medicare Benefits Schedule (MBS) Review is comprehensive and regular consultation with stakeholders, including consumers of MBS services.

Page last updated: 20 October 2017

Have your say
Timeline for consultations
How it works
Why we want your input
Previous Consultations

There are currently no open consultations

Timeline for consultations

The Taskforce has endorsed a number of reports to be released for public consultation between June and August 2017.

Download the MBS Review 2017 public consultation plan to see full timeline.

How it works

Step 1: Draft recommendations from clinical committees and the Principles and Rules Committee are publically released and stakeholders are invited to give their feedback as an ongoing process.

Step 2: Following the public consultation period, the Clinical Committees will assess the advice from public consultation and decide whether any changes are needed to the recommendations.

Step 3: The Clinical Committees will then send the recommendations to the Taskforce.

Step 4: The Taskforce will consider the recommendations as well as the information provided by the public in order to make sure that all the important concerns are addressed.

Step 5: The Taskforce will then provide recommendations to Government.

Why we want your input

Public consultation is an opportunity for the Australian public, including health professionals, to have their say about recommendations proposed by the Clinical Committees, prior to these recommendations being made to Government.

Public consultation with stakeholders, including consumers of MBS services is integral to the process established by the Taskforce.

Stakeholder input has been critical in shaping the Review to date. It is important that this process is upheld through this Review process.

Previous consultations

The Taskforce has previously undertaken a number of consultations.

The editions of the reports available include:

  • Report published for the purpose of public consultation
  • Addendum to the public consultation report following consideration of public feedback by the clinical committee and Taskforce

Round 5: 22 August – 4 October 2017

Round 4: 7 June – 21 July 2017

Round 3: 9 September – 7 October 2016

Round 2: 18 December 2015 – 8 February 2016

Round 1: 27 September – 9 November 2015